A wider-than-expected first quarter loss was experienced because of high input costs, inflation and supply and demand imbalances, impacting performance in all units.

Cultivated meat and seafood will soon be taste tested under limited conditions in the country in nan agreement passed by the Dutch House of Representatives in 2022.

This expands the company’s line of cultured meat for the pet food market.

The company will use the fresh money to drive regulatory approval of its first products, expanding research work and initiating pilot production.

The company says its approach utilizes healthy, living animals and can produce more meat per cow.

The insulin substituents can reduce the cost and development time for producing cultivated meat at scale.

Last November, the U.S. FDA announced that it had completed an evaluation of UPSIDE Foods’ cultured animal cell foods and had “no further questions at this time about the firm’s safety conclusion.” While the FDA pointed out that there were still other regulatory hurdles to overcome for cell-cultured foods could be brought to market, namely from the USDA and FSIS, the announcement was seen by many as an important step in adding another option to the alternative protein space—one of a number of trends involving alternative protein in the past year. 

The new system is designed to eliminate barriers faced by current cultivated meat approaches that rely on enormous bioreactors infeasible for scalable animal cell cultivation.

The capital deployment in Israel and Singapore is designed to support scale-up in key markets.

Once operational, the 200,000-sq-ft facility will reportedly be the largest cultivated meat production center in the world.